Literature DB >> 14753426

Thrombin exacerbates brain edema in focal cerebral ischemia.

Y Hua1, J Wu, R F Keep, J T Hoff, G Xi.   

Abstract

Thrombin contributes to edema formation after intracerebral hemorrhage. Recent studies suggest that thrombin may also play a role in ischemic brain damage. In the present study, adult male Sprague-Dawley rats were anesthetized with pentobarbital. Middle cerebral artery (MCA) was occluded using the suture method. We found that brain thrombin activity was elevated after permanent MCA occlusion as was prothrombin messenger RNA expression. Intracerebral injection of a thrombin inhibitor, hirudin, reduced neurological deficits following cerebral ischemia. In contrast, intracerebral administration of exogenous thrombin (at a dose that is non-toxic to normal brain), markedly exacerbated brain edema after transient focal cerebral ischemia. These results indicate that extravascular thrombin inhibition may be a new therapeutic target for cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753426     DOI: 10.1007/978-3-7091-0651-8_34

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  15 in total

Review 1.  Volume-dependent osmolyte efflux from neural tissues: regulation by G-protein-coupled receptors.

Authors:  Stephen K Fisher; Tooba A Cheema; Daniel J Foster; Anne M Heacock
Journal:  J Neurochem       Date:  2008-06-02       Impact factor: 5.372

2.  Quantitative detection of thrombin activity in an ischemic stroke model.

Authors:  Doron Bushi; Joab Chapman; Aviva Katzav; Efrat Shavit-Stein; Noa Molshatzki; Nicola Maggio; David Tanne
Journal:  J Mol Neurosci       Date:  2013-07-31       Impact factor: 3.444

3.  Is there a place for cerebral preconditioning in the clinic?

Authors:  Richard F Keep; Michael M Wang; Jianming Xiang; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2010-01-14       Impact factor: 6.829

Review 4.  Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

Authors:  J Marc Simard; Thomas A Kent; Mingkui Chen; Kirill V Tarasov; Volodymyr Gerzanich
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

5.  Short period of early reperfusion aggravates blood-brain barrier dysfunction during permanent focal ischemia in rats.

Authors:  Johannes Woitzik; Axel Hohenstein; Nils Hecht; Eric Juettler; Lothar Schilling
Journal:  Transl Stroke Res       Date:  2010-09-04       Impact factor: 6.829

6.  Thrombin-induced cerebral hemorrhage: role of protease-activated receptor-1.

Authors:  Yingying Cheng; Guohua Xi; Hang Jin; Richard F Keep; Jiachun Feng; Ya Hua
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

Review 7.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

8.  PAR-1 antagonist SCH79797 ameliorates apoptosis following surgical brain injury through inhibition of ASK1-JNK in rats.

Authors:  Anatol Manaenko; Xuejun Sun; Cherine H Kim; Junhao Yan; Qingyi Ma; John H Zhang
Journal:  Neurobiol Dis       Date:  2012-09-19       Impact factor: 5.996

9.  Baicalin attenuates focal cerebral ischemic reperfusion injury by inhibition of protease-activated receptor-1 and apoptosis.

Authors:  Qing-bo Zhou; Cheng-zhu Duan; Qing Jia; Ping Liu; Lu-yang Li
Journal:  Chin J Integr Med       Date:  2013-03-16       Impact factor: 1.978

10.  The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing.

Authors:  Jason R Cannon; Ya Hua; Rudy J Richardson; Guohua Xi; Richard F Keep; Timothy Schallert
Journal:  Behav Brain Res       Date:  2007-06-13       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.